Glucosamine Market Size & Industry Share - Growth Trends & Forecasts (2023 - 2030)

Glucosamine Market Dynamics - (DRO) :

Key Drivers :

Increasing use of glucosamine supplements to improve bone & joint health is propelling the glucosamine market growth

Glucosamine is a natural chemical compound present in the human body. The production of glucosamine in the human body reduces with age, which leads to symptoms such as mild to moderate knee osteoarthritis, joint pains, diabetes, and others. Glucosamine plays an important role in making glycosaminoglycans and glycoproteins, which are essential building blocks of many parts of your joints, including ligaments, tendons, cartilage, and synovial fluid. Owing to this, glucosamine is actively used as an essential dietary supplement for maintaining overall bone & joint health in humans. The increasing prevalence of bone related disorders across various countries worldwide is a prominent factor driving the growth of the global glucosamine market. For instance, according to the report by the Australian Bureau of Statistics, in March 2022, 12.5% of the population across Australia is found to be diagnosed with Arthritis, and 3.6% of the population with Osteoporosis. This high prevalence of bone-related disorders is leading to the increased demand for glucosamine supplements for the treatment of this disease, which in turn, is fuelling the market growth.

Growing consumer awareness regarding the benefits of dietary supplements

The growing emphasis on health and wellness among consumers worldwide is leading to the increased demand for nutritional as well as dietary supplements for overall well-being. Supplements such as glucosamine are perceived as a convenient and accessible means to address various health concerns in the human body. Overall growth in the consumption of dietary supplements among consumers globally is benefiting the growth of the global glucosamine market. For instance, according to the report published by the National Institute of Health in June 2023, the U.S. sale of dietary supplements in 2020 accounted for USD 55.7 billion, which was USD 34.5 billion in 2019. The significant growth in the sale of dietary supplements across the U.S. is increasing the demand for glucosamine for maintaining overall bone health. The geriatric population is the largest population segment diagnosed with bone-related disorders. This increasing number of geriatric populations along with the growing trend of fitness and sports is also driving the growth of glucosamine worldwide.

Key Restraints :

Side effects associated with the use of glucosamine is likely to deter market growth

The global demand for glucosamine as an effective supplement for the treatment of bone-related disorders is increasing. However, the consumption of glucosamine in some humans can lead to various side effects such as indigestion, constipation, diarrhea, headaches, rashes, and others. These side effects can range from mild to severe depending upon the resistance and acceptance capacity of person to person. People diagnosed with diseases such as diabetes, asthma, allergies, blood circulation issues, and others must be more aware of consuming glucosamine in the form of supplements. According to a report by the National Institute of Health, glucosamine enhances body weight gain and reduces insulin response. Another study found that the consumption of glucosamine might affect the glucose levels in the body, which makes it unsuitable for people with diabetes or glucose intolerance. Therefore, the aforementioned factors are anticipating the glucosamine market growth.

Future Opportunities :

The increasing prevalence of cancer is likely to accelerate market growth

Glucosamine possesses properties such as anti-cancer and anti-inflammatory benefits, due to which it plays a significant role in decreasing death rates from various types of cancers such as breast cancer, prostate cancer, colorectal cancer, and lung cancer. It shows anti-tumor effects and progresses the effects of apoptosis in the human body, by inducing autophagic death of cancer cells, reversing tumor drug resistance, anti-tumor angiogenesis, and inhibiting the expression of matrix metalloproteinases. Studies have shown that glucosamine supplementation can lower the risk of lung cancer by 16%, 32% lower risk of kidney cancer mortality, 5% lower risk of overall cancer mortality, and 24% lower risk of rectum cancer mortality. Hence, the increasing prevalence of cancer across the globe is expected to provide lucrative glucosamine market opportunities over the estimated period. For instance, according to the report by the American Cancer Society in January 2023, lung cancer accounted for the second most common cancer. Thus, this high prevalence of cancer and cancer-related deaths and the potential application of glucosamine in reducing the mortality rate of cancer is likely to drive the market growth over the forecast period.

Top Key Players & Market Share Insights:

The glucosamine market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the market include-